Efficacy and safety of furmonertinib in patients with EGFR‑mutant advanced lung adenocarcinoma after failure of multiple lines of therapy: A single‑center retrospective study.
Saved in:
| Title: | Efficacy and safety of furmonertinib in patients with EGFR‑mutant advanced lung adenocarcinoma after failure of multiple lines of therapy: A single‑center retrospective study. |
|---|---|
| Authors: | Zheng, Yumin1 (AUTHOR), Lu, Xingyu2 (AUTHOR), Dong, Huijing1 (AUTHOR), Li, Jia1 (AUTHOR), Shen, Yulei1 (AUTHOR), Liu, Zhening1 (AUTHOR), Cui, Huijuan3 (AUTHOR) edna@sc-mch.cn |
| Source: | Oncology Letters. Jul2025, Vol. 30 Issue 1, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
